WASHINGTON--(BUSINESS WIRE)--Palantir Technologies announced today that it has been awarded a three-year, $7 million contract by the National Institutes of Health (NIH). Palantir will deploy its software as the collaborative scientific platform for the National Center for Advancing Translational Sciences (NCATS) and its related organizations.
NCATS, one of the NIH’s 27 Institutes and Centers, aims to remove bottlenecks in research pipelines and speed the delivery of new drugs, diagnostics, and medical devices to patients. The organization’s scientists will utilize Palantir’s software to combine proprietary and public research data in one secure interface—screening, genomics, and other high-throughput biological data will be integrated into the platform in order to advance the translational research of NCATS teams.
“NCATS’ mission is to get more treatments to patients more quickly,” said Andrew Girvin, Head of Biomedical R&D at Palantir Technologies. “By bringing together disparate data into one interface, researchers will soon benefit from greater insights in a fraction of the time. Ultimately, the goal is to help accelerate the discovery of new therapies for cancer and other illnesses.”
About Palantir
Palantir Technologies is a software company that builds enterprise data platforms for organizations with highly complex and sensitive data environments. From building safer cars and planes, to discovering new drugs and combating terrorism, Palantir helps customers across the public, private, and nonprofit sectors transform the way they use their data. Palantir is headquartered in Palo Alto, with major offices in New York, Washington, D.C., London, and Paris. Additional information is available at http://www.palantir.com.
